Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet’s syndrome

• Published in: Rheumatology international Vol. 42; no. 10; pp. 1741 - 1750
• Main Authors: Ozdede, Ayse, Nohut, Okan Kadir, Atli, Zeynep, Tok, Yeşim Tuyji, Guner, Sabriye, Yilmaz, Erkan, Ucar, Didar, Uygunoglu, Ugur, Hamuryudan, Vedat, Seyahi, Emire
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2022; Springer Nature B.V
• Subjects: Antibodies; Coronaviruses; COVID-19 vaccines; Medicine; Medicine & Public Health; Observational Research; Rheumatology; Severe acute respiratory syndrome coronavirus 2; Vein & artery diseases; COVID-19; Behcet’s syndrome; BioNTech; Humoral; Vaccine; CoronaVac; Immunity

There are limited data about humoral response to vaccine in Behçet’s syndrome (BS). We compared SARS-CoV-2 antibody response after two doses of inactivated (Sinovac/CoronaVac) or mRNA (Pfizer/BioNTech) vaccines in patients with BS and healthy controls (HCs). We studied 166 (92M/74F) patients with BS...